poisar

Stocks · News reference

Barclays Adjusts Price Target on Ionis Pharmaceuticals to $70 From $85, Keeps Overweight Rating

Fiscal.ai

Barclays has lowered its price target for Ionis Pharmaceuticals from $85 to $70 while maintaining an Overweight rating on the stock.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading